Location: Home
  • search
  • go
  • Relate News
  • 5/20/2025'China's Ozempic' may vie with Eli Lilly, Novo Nordisk for global weig...
  • 5/16/2025SMEI: China's Pharmaceutical Industry Seeks Stability and Innovation A...
  • 5/16/2025US Tariffs on Pharmaceuticals Could Hit Chinese Export Firms’ Profit ...
  • 5/16/2025ArkBio Reports Positive Mid-Stage Results for Anti-Fibrotic Candidate ...
  • 5/16/2025China Approves Haisco Pharma's Anrikefon (HSK21542) for Postoperative ...
  • 5/16/2025CSPC and Cipla Forge Exclusive U.S. Licensing Deal for Irinotecan Lipo...
  • 5/16/2025China Approves Xuanzhu Bio's Birociclib for HR+/HER2- Advanced Breast ...
  • 5/16/2025NMPA Approves CANbridge's Velaglucerase Beta for Gaucher Disease
  • 5/16/2025NMPA Orders Package Insert/Label Update for Ranitidine Injection Amid ...
  • 5/16/2025US Push to Decouple from China May Spike Drug Costs, Experts Warn
  • 5/16/2025Nuance Pharma Reports Positive Phase 3 Results for Ensifentrine in Chi...
  • 5/16/2025Viva Biotech Unveils Proprietary AI Platform to Reshape Drug Discovery
  • 5/16/2025WuXi Biologics Offloads German Plant to Terumo, Refocuses on Singapore...
  • 5/15/2025Novartis Gains NMPA Approval for Expanded Use of Kisqali in Early Brea...
  • 5/15/2025NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...
  • 5/15/2025Hengrui Aims to Raise $1.27B in Hong Kong IPO
  • 5/14/2025NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M
  • 5/14/2025BRL Medicine's Allogeneic CAR-T Therapy Shows Promising Results in Ref...
  • 5/14/2025Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...
  • 5/14/2025RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...
  • 5/14/2025CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...
  • 5/14/2025Beigene Submits New Indication Application for BCL2 Inhibitor Sonrotoc...
  • 5/14/2025Six Drugs Granted Priority Review as China Registers Over 1,100 Produc...
  • 5/14/2025R&D Spending Rises at 276 Chinese Drugmakers Despite Revenue Pressures
  • 5/14/2025CDE Issues the List of Reference Formulations for GQCE Studies (92nd B...
  • 5/14/2025Chinese Drugmakers May Weather Trump's Tariff Threats With Cost Edge, ...
  • 5/13/2025China Expands Geriatric Services at Major Hospitals as Elderly Populat...
  • 5/12/2025Lepu's Miracogen Launches Phase 3 Trial of Novel EGFR-Targeting ADC Co...
  • 5/12/2025AusperBio Reports Promising Phase IIb Results for AHB-137 in Chronic H...
  • 5/12/2025CureGene Unveils Potent Liver-Targeted THR-β Prodrug CG-0416 with Pro...
  • Page:38/803 Total number of articles:24071: [First][<<] [36] [37] [38] [39] [40] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group